With the slowdown in world economic growth, the Peripheral Intravenous (IV) Catheter Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Peripheral Intravenous (IV) Catheter market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, Stratagem Market Insights analysts believe that in the next few years, Peripheral Intravenous (IV) Catheter market size will be further expanded, we expect that by 2026, The market size of the Peripheral Intravenous (IV) Catheter will reach XXX million $.
A peripheral intravenous (IV) catheter is a commonly used vascular access in medicine. The catheter contains a slim flexible plastic tube that can be inserted in the peripheral vein in a patient’s arm using a hollow needle, which can then be withdrawn, and medication or fluids thereafter administered. Peripheral IV catheter is classified by the U.S. FDA in 21 CFR, section 880.5200 intravascular catheter
The increasing prevalence of chronic diseases is expected to propel the growth of the global peripheral intravenous catheter market over the forecast period. For instance, according to the study, ‘Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)’, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018. Moreover, the approval and launch of new products are also expected to aid in the growth of the market. For instance, in March 2018, Smiths Medical received the U.S. FDA clearance for its DeltaVen Closed System Catheter, a product developed by Delta Med SpA.
Moreover, developments in improving patient safety and the effectiveness of IV therapy are also expected to aid in the growth of the market. For instance, in June 2019, ivWatch, a biosensor technology company focused on enhancing patient safety and the effectiveness of IV therapy, secured two patent grants for core product technologies in order to expand its foothold in Australia and Europe.
However, factors such as lack of training in the use of peripheral IV catheters, complications due to the use of peripheral IV catheters that include, skin infections, redness, itching, and pain, and high cost of advanced catheters are expected to hamper the growth of the global peripheral intravenous catheter market.
R&D related to peripheral IV catheters is expected to offer lucrative growth opportunities for players in the market. For instance, in October 2019, researchers from Hartford Hospital (Hartford, Conn.) and PICC Excellence reported that implementing a standardized set of best practices for inserting peripheral IV catheters results in significant clinical and economic benefits, in the Journal of the Association for Vascular Access.
Key Takeaways:
- Increasing prevalence of chronic diseases to augment the growth of the global peripheral intravenous catheter market over the forecast period
- However, complications due to the use of peripheral IV catheters are expected to hinder the growth of the market
- Major players operating in the global peripheral intravenous catheter market include Becton, Dickinson and Company, B. Braun Melsungen AG, Smith Medical, Terumo Corporation, C. R. Bard, Inc., Tangent Medical, Velano Vascular Inc., and Vygon Group
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume, and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment, etc. cover different segment market sizes, both volume, and value. Also cover different industries client's information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
╼ B. Braun Melsungen
╼ C.R. Bard
╼ Smiths Medical
╼ TERUMO CORPORATION
╼ AngioDynamics
╼ APEXMED International
╼ Delta Med
╼ EXELINT International
╼ GaltNeedleTech
╼ Global Medikit
╼ Hospira
╼ NIPRO Medical
╼ RenovoRx
Section 4: Region Segmentation
╼ North America Country (United States, Canada)
╼ South America
╼ Asia Country (China, Japan, India, Korea)
╼ Europe Country (Germany, UK, France, Italy)
╼ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Type Segmentation
Product Type Segmentation ➟
╼ Short PIVCs
╼ Integrated Or Closed PIVCs
Industry Segmentation ➟
╼ Hospitals
╼ Clinics
╼ ASCs
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
